Goldman Sachs’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-519,107
| Closed | -$4.73M | – | 6616 |
|
|
2025
Q2 | $4.73M | Buy |
519,107
+81,054
| +19% | +$596K | ﹤0.01% | 3474 |
|
|
2025
Q1 | $3.48M | Sell |
438,053
-104,194
| -19% | -$763K | ﹤0.01% | 3697 |
|
|
2024
Q4 | $2.94M | Sell |
542,247
-228,074
| -30% | -$1.39M | ﹤0.01% | 3967 |
|
|
2024
Q3 | $5.56M | Buy |
770,321
+18,756
| +2% | +$172K | ﹤0.01% | 3250 |
|
|
2024
Q2 | $8.16M | Buy |
751,565
+228,311
| +44% | +$2.93M | ﹤0.01% | 2707 |
|
|
2024
Q1 | $9.81M | Buy |
523,254
+46,748
| +10% | +$1.08M | ﹤0.01% | 2471 |
|
|
2023
Q4 | $10.3M | Buy |
476,506
+163,400
| +52% | +$3.24M | ﹤0.01% | 2500 |
|
|
2023
Q3 | $6.44M | Sell |
313,106
-198,859
| -39% | -$5.74M | ﹤0.01% | 2763 |
|
|
2023
Q2 | $24.1M | Sell |
511,965
-434,173
| -46% | -$21.6M | 0.01% | 1692 |
|
|
2023
Q1 | $39.7M | Buy |
946,138
+22
| +0% | +$946 | 0.01% | 1235 |
|
|
2022
Q4 | $36.1M | Sell |
946,116
-165,406
| -15% | -$6.32M | 0.01% | 1441 |
|
|
2022
Q3 | $43.5M | Buy |
1,111,522
+5,246
| +0.5% | +$203K | 0.01% | 1210 |
|
|
2022
Q2 | $35.7M | Buy |
1,106,276
+792,819
| +253% | +$26.6M | 0.01% | 1386 |
|
|
2022
Q1 | $10.4M | Sell |
313,457
-131,502
| -30% | -$4.94M | ﹤0.01% | 2655 |
|
|
2021
Q4 | $18.9M | Sell |
444,959
-27,535
| -6% | -$1.15M | ﹤0.01% | 2154 |
|
|
2021
Q3 | $20.9M | Sell |
472,494
-35,012
| -7% | -$1.61M | 0.01% | 2028 |
|
|
2021
Q2 | $28.8M | Buy |
507,506
+50,599
| +11% | +$3.58M | 0.01% | 1733 |
|
|
2021
Q1 | $34.2M | Sell |
456,907
-197,853
| -30% | -$16.2M | 0.01% | 1475 |
|
|
2020
Q4 | $56.6M | Buy |
654,760
+121,525
| +23% | +$8.96M | 0.02% | 1033 |
|
|
2020
Q3 | $32.6M | Sell |
533,235
-279,550
| -34% | -$14.2M | 0.01% | 1342 |
|
|
2020
Q2 | $33.8M | Buy |
812,785
+67,197
| +9% | +$2.44M | 0.01% | 1267 |
|
|
2020
Q1 | $21.4M | Buy |
745,588
+245,596
| +49% | +$14.2M | 0.01% | 1456 |
|
|
2019
Q4 | $36.1M | Buy |
499,992
+169,434
| +51% | +$20.8M | 0.01% | 1392 |
|
|
2019
Q3 | $46.4M | Sell |
330,558
-9,448
| -3% | -$1.58M | 0.02% | 1153 |
|
|
2019
Q2 | $62.3M | Buy |
340,006
+12,942
| +4% | +$2.21M | 0.02% | 1001 |
|
|
2019
Q1 | $52M | Buy |
327,064
+60,260
| +23% | +$8.73M | 0.02% | 1089 |
|
|
2018
Q4 | $25.6M | Buy |
266,804
+42,661
| +19% | +$4.88M | 0.01% | 1596 |
|
|
2018
Q3 | $31.7M | Sell |
224,143
-198,772
| -47% | -$30.7M | 0.01% | 1568 |
|
|
2018
Q2 | $66.2M | Buy |
422,915
+98,206
| +30% | +$15.4M | 0.02% | 1013 |
|
|
2018
Q1 | $52.3M | Buy |
324,709
+99,890
| +44% | +$17M | 0.02% | 1169 |
|
|
2017
Q4 | $37M | Sell |
224,819
-113,259
| -34% | -$11M | 0.01% | 1497 |
|
|
2017
Q3 | $21.1M | Buy |
338,078
+99,548
| +42% | +$7.82M | 0.01% | 1933 |
|
|
2017
Q2 | $19M | Buy |
238,530
+76,663
| +47% | +$5.54M | 0.01% | 1979 |
|
|
2017
Q1 | $11.5M | Buy |
161,867
+7,940
| +5% | +$465K | ﹤0.01% | 2304 |
|
|
2016
Q4 | $7.86M | Sell |
153,927
-157,553
| -51% | -$7.43M | ﹤0.01% | 2652 |
|
|
2016
Q3 | $14.3M | Buy |
311,480
+165,899
| +114% | +$6.75M | 0.01% | 2160 |
|
|
2016
Q2 | $4.39M | Buy |
145,581
+66,257
| +84% | +$2.21M | ﹤0.01% | 2971 |
|
|
2016
Q1 | $2.54M | Buy |
79,324
+47,413
| +149% | +$1.67M | ﹤0.01% | 3270 |
|
|
2015
Q4 | $1.86M | Buy |
31,911
+4,129
| +15% | +$205K | ﹤0.01% | 3694 |
|
|
2015
Q3 | $1.18M | Sell |
27,782
-5,997
| -18% | -$370K | ﹤0.01% | 4310 |
|
|
2015
Q2 | $2.47M | Buy |
33,779
+29,098
| +622% | +$1.87M | ﹤0.01% | 3632 |
|
|
2015
Q1 | $235K | Sell |
4,681
-29,373
| -86% | -$1.26M | ﹤0.01% | 5874 |
|
|
2014
Q4 | $1.25M | Sell |
34,054
-24,082
| -41% | -$898K | ﹤0.01% | 4334 |
|
|
2014
Q3 | $1.83M | Buy |
+58,136
| New | +$1.68M | ﹤0.01% | 4029 |
|
Other funds holding SAGE
IA
HNB